###begin article-title 0
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
Association between Frequency of Chromosomal Aberrations and Cancer Risk Is Not Influenced by Genetic Polymorphisms in GSTM1 and GSTT1
###end article-title 0
###begin p 1
These two authors contributed equally to the present study.
###end p 1
###begin p 2
The authors declare they have no competing financial interests.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
The frequency of chromosomal aberrations (CA) in peripheral blood lymphocytes of healthy individuals has been associated with cancer risk. It is presently unclear whether this association is influenced by individual susceptibility factors such as genetic polymorphisms of xenobiotic-metabolizing enzymes.
###end p 4
###begin title 5
Objectives
###end title 5
###begin p 6
###xml 53 55 53 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S-</italic>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
To evaluate the role of polymorphisms in glutathione S-transferase (GST) M1 (GSTM1) and theta 1 (GSTT1) as effect modifiers of the association between CA and cancer risk.
###end p 6
###begin title 7
Methods
###end title 7
###begin p 8
A case-control study was performed pooling data from cytogenetic studies carried out in 1974-1995 in three laboratories in Italy, Norway, and Denmark. A total of 107 cancer cases were retrieved from national registries and matched to 291 controls. The subjects were classified as low, medium, and high by tertile of CA frequency. The data were analyzed by setting up a Bayesian model that included prior information about cancer risk by CA frequency.
###end p 8
###begin title 9
Results
###end title 9
###begin p 10
###xml 70 76 70 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">medium</sub>
###xml 89 95 89 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">medium</sub>
###xml 146 150 146 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sub>
###xml 299 303 299 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sub>
###xml 493 497 493 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sub>
###xml 551 555 551 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sub>
###xml 610 614 610 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sub>
The association between CA frequency and cancer risk was confirmed [ORmedium (odds ratio)medium = 1.5, 95% credibility interval (CrI), 0.9-2.5; ORhigh = 2.8, 95% CrI, 1.6-4.6], whereas no effect of the genetic polymorphism was observed. A much stronger association was seen in the Italian subset (ORhigh= 9.4, 95% CrI, 2.6-28.0), which was characterized by a lower technical variability of the cytogenetic analysis. CA level was particularly associated with cancer of the respiratory tract (ORhigh= 6.2, 95% CrI, 1.5-20.0), the genitourinary tract (ORhigh = 4.0, 95% CrI, 1.4-10.0), and the digestive tract (ORhigh = 2.8, 95% CrI, 1.2-5.8).
###end p 10
###begin title 11
Conclusions
###end title 11
###begin p 12
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
Despite the small size of the study groups, our results substantiate the cancer risk predictivity of CA frequency, ruling against a strong modifying effect of GSTM1 and GSTT1 polymorphisms.
###end p 12
###begin p 13
###xml 294 314 294 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-ehp-117-203">Boffetta et al. 2007</xref>
###xml 316 335 316 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7-ehp-117-203">Bonassi et al. 1995</xref>
###xml 337 341 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp-117-203">2000</xref>
###xml 343 347 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11-ehp-117-203">2004</xref>
###xml 349 368 349 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-ehp-117-203">Br&#248;gger et al. 1990</xref>
###xml 370 388 370 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-ehp-117-203">Hagmar et al. 1994</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-ehp-117-203">1998</xref>
###xml 396 400 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-ehp-117-203">2004</xref>
###xml 402 418 402 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29-ehp-117-203">Liou et al. 1999</xref>
###xml 420 439 420 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37-ehp-117-203">Rossner et al. 2005</xref>
###xml 558 577 558 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7-ehp-117-203">Bonassi et al. 1995</xref>
###xml 579 597 579 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-ehp-117-203">Hagmar et al. 1994</xref>
###xml 599 603 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-ehp-117-203">1998</xref>
###xml 727 746 727 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp-117-203">Bonassi et al. 2000</xref>
###xml 849 871 849 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41-ehp-117-203">Smerhovsky et al. 2002</xref>
###xml 710 717 <span type="species:ncbi:4097">tobacco</span>
During the last few decades, evidence concerning the role of chromosomal aberrations (CA) in carcinogenesis has been enriched by a number of epidemiologic studies showing that high CA frequencies in peripheral blood lymphocytes of healthy individuals are associated with increased cancer risk (Boffetta et al. 2007; Bonassi et al. 1995, 2000, 2004; Brogger et al. 1990; Hagmar et al. 1994, 1998, 2004; Liou et al. 1999; Rossner et al. 2005). A case-control study nested within ESCH (European Study Group of Cytogenetic Biomarkers and Health) cohort studies (Bonassi et al. 1995; Hagmar et al. 1994, 1998) found that the strength of such association is not influenced by occupational exposure to carcinogens or tobacco smoking (Bonassi et al. 2000). Contrasting results were reported by other investigations, such as a cohort study on Czech workers (Smerhovsky et al. 2002) describing a stronger association between CA frequency and cancer incidence in miners exposed to radon. Whether the CA-cancer association reflects (occasionally undetected) exposure to carcinogens, individual susceptibility to carcinogens, some form of chromosomal instability, or a causal role of chromosomal rearrangements in the carcinogenic process is still an open issue.
###end p 13
###begin p 14
###xml 217 228 217 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-ehp-117-203">Norppa 2004</xref>
###xml 434 440 <span type="species:ncbi:9606">people</span>
A striking amount of data supports the hypothesis that individual characteristics associated with cancer risk, such as inherited differences in metabolic enzymes or DNA repair capacity, may also modify CA occurrence (Norppa 2004). These findings raise the obvious question of whether the association between CA and cancer risk depends on individual metabolism and DNA repair capability, so that CA would better predict cancer risk in people with an unfavorable genotype. This question can be assessed by incorporating genotype data to the CA-cancer studies, but such an approach has not been applied previously, as DNA samples have not been readily available.
###end p 14
###begin p 15
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 294 313 294 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-ehp-117-203">Bolt and Thier 2006</xref>
###xml 315 324 315 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36-ehp-117-203">Parl 2005</xref>
###xml 578 597 578 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-ehp-117-203">Bolt and Thier 2006</xref>
###xml 599 608 599 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36-ehp-117-203">Parl 2005</xref>
###xml 721 722 721 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 900 903 900 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 960 979 960 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6-ehp-117-203">Bolufer et al. 2006</xref>
###xml 981 1000 981 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-ehp-117-203">Bolt and Thier 2006</xref>
###xml 1002 1022 1002 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-ehp-117-203">Carlsten et al. 2008</xref>
###xml 1024 1042 1024 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-ehp-117-203">Hiyama et al. 2008</xref>
###xml 1044 1053 1044 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36-ehp-117-203">Parl 2005</xref>
###xml 1055 1070 1055 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39-ehp-117-203">Shi et al. 2008</xref>
###xml 1072 1090 1072 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43-ehp-117-203">Vineis et al. 2007</xref>
###xml 1092 1109 1092 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45-ehp-117-203">White et al. 2008</xref>
###xml 1124 1130 1124 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1;</italic>
###xml 1163 1168 1163 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 1417 1436 1417 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6-ehp-117-203">Bolufer et al. 2006</xref>
###xml 1438 1457 1438 1457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-ehp-117-203">Bolt and Their 2006</xref>
###xml 1459 1477 1459 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-ehp-117-203">Hiyama et al. 2008</xref>
###xml 1479 1488 1479 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36-ehp-117-203">Parl 2005</xref>
###xml 1490 1505 1490 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39-ehp-117-203">Shi et al. 2008</xref>
###xml 1507 1524 1507 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45-ehp-117-203">White et al. 2008</xref>
Among the most frequently studied polymorphisms are those concerning the metabolism of xenobiotics, in particular glutathione S-transferases (GSTs). GSTs catalyze the conjugation between glutathione and reactive xenobiotic compounds in a pathway that leads to thioethers excreted in the urine (Bolt and Thier 2006; Parl 2005). The major biological function of GSTs is considered to be protection against electrophilic chemical species, although metabolic activation involving GST-mediated glutathione conjugation has also been described (e.g., for some chlorinated substrates) (Bolt and Thier 2006; Parl 2005). Detoxification by glutathione conjugation can represent a minor (e.g., styrene oxide) or a major (e.g., benzo[a]pyrene) metabolic pathway for many genotoxic agents. Given the importance of GSTs in the detoxification of electrophilic carcinogens, the possible influence of polymorphisms in GST genes on cancer risk has been investigated extensively (Bolufer et al. 2006; Bolt and Thier 2006; Carlsten et al. 2008; Hiyama et al. 2008; Parl 2005; Shi et al. 2008; Vineis et al. 2007; White et al. 2008). The GST M1 (GSTM1; BC036805, GenBank) and theta 1 (GSTT1; X79389, GenBank) genes have received much attention because of the high prevalence of homozygous deletions resulting in null genotypes with a decreased ability to detoxify carcinogenic compounds, placing null individuals at increased cancer risk (Bolufer et al. 2006; Bolt and Their 2006; Hiyama et al. 2008; Parl 2005; Shi et al. 2008; White et al. 2008).
###end p 15
###begin p 16
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
The availability in the ESCH database of a group of subjects genotyped for GSTM1 and GSTT1 genes in three national laboratories allowed us to address the question if these genetic polymorphisms can modify the strength of the association between CA and cancer risk. In a group of subjects from Pisa, Italy-not included in the original ESCH database-cytogenetic slides could be retrieved from freezers, stained, and scored all together, minimizing the impact of protocol variation, reagents drift, and scorer heterogeneity.
###end p 16
###begin p 17
The small size of study groups is a common limitation of biomarker validation studies. The presence of sparse data and missing covariates are conditions for which the Bayesian paradigm presents some advantages over the frequentist paradigm. In particular, Bayes' rule opens the possibility of improving the estimation of the parameters of interest by including the prior probability, based on knowledge already available-in this case, the association of CA with cancer risk.
###end p 17
###begin p 18
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
This study aimed at a) confirming the presence of the association between CA and cancer risk in a partially new data set, and b) evaluating the role of GSTM1 and GSTT1 polymorphisms as effect modifiers of this association. Ancillary but still important aims were to evaluate the impact of reduced laboratory/technical variability on risk estimates and to verify whether Bayesian statistics can provide reliable estimates in small strata.
###end p 18
###begin title 19
Material and Methods
###end title 19
###begin title 20
Subjects
###end title 20
###begin p 21
###xml 368 373 368 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 378 383 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 472 491 472 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp-117-203">Bonassi et al. 2000</xref>
###xml 493 511 493 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-ehp-117-203">Hagmar et al. 1998</xref>
###xml 513 517 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-ehp-117-203">2004</xref>
###xml 608 626 608 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35-ehp-117-203">Norppa et al. 2006</xref>
###xml 588 593 <span type="species:ncbi:9606">Human</span>
A nested case-control study was performed pooling data from cytogenetic surveillance studies carried out from 1974 to 1995 at the Department of Biology, University of Pisa, Pisa, Italy; the Department of Occupational Medicine, Telemark Hospital, Skien, Norway; and the Danish National Institute of Occupational Health, Copenhagen, Denmark. These laboratories analyzed GSTM1 and GSTT1 polymorphisms in subjects screened for CA and followed up in the framework of the ESCH (Bonassi et al. 2000; Hagmar et al. 1998, 2004) and the more recent CancerRiskBiomarkers (Cytogenetic Biomarkers and Human Cancer Risk) (Norppa et al. 2006) collaborative projects.
###end p 21
###begin p 22
###xml 188 207 188 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp-117-203">Barale et al. 1998a</xref>
###xml 209 214 209 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-ehp-117-203">1998b</xref>
###xml 216 233 216 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-ehp-117-203">Landi et al. 1999</xref>
###xml 235 254 235 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31-ehp-117-203">Milillo et al. 1996</xref>
###xml 386 405 386 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-ehp-117-203">Br&#248;gger et al. 1990</xref>
###xml 407 427 407 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-ehp-117-203">Hansteen et al. 1978</xref>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-ehp-117-203">1984</xref>
###xml 565 584 565 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-ehp-117-203">Knudsen et al. 1992</xref>
The Italian cohort consisted of 1,650 healthy subjects selected from the general population living in three areas in Tuscany (Pisa, Cascina, and Navacchio) enrolled between 1991 and 1993 (Barale et al. 1998a, 1998b; Landi et al. 1999; Milillo et al. 1996). The Norwegian cohort included 681 healthy subjects, either occupationally exposed or referents, collected between 1974 and 1990 (Brogger et al. 1990; Hansteen et al. 1978, 1984). The Danish data arose from a biomonitoring study conducted in 1987 in a group of 226 male stainless steel welders and referents (Knudsen et al. 1992). Information was gathered on demographic, occupational, and lifestyle factors at the time of blood sampling.
###end p 22
###begin p 23
###xml 382 385 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 441 446 441 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 462 467 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
In the Nordic countries, all malignant tumors diagnosed from the date of CA testing until the end of the follow-up (2006 in Norway, and 2003 in Denmark) were retrieved through linkage from national cancer registries. In Italy, the cause of death was obtained from the municipality of residence (2006). At the end of the follow-up, a total of 107 cancer cases with information about GST polymorphism were tracked (105/107 cases genotyped for GSTM1 and 77/107 for GSTT1). Within each national cohort, controls were matched with their corresponding case by sex, age (+/- 10 years), and year of CA test (+/- 5 years). The overall cases to controls ratio was around 1:3 (107 cases/291 controls).
###end p 23
###begin p 24
###xml 160 182 160 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13-ehp-117-203">Buckton and Evans 1973</xref>
###xml 650 661 644 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38-ehp-117-203">Savage 1976</xref>
###xml 1052 1071 1046 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp-117-203">Barale et al. 1998a</xref>
###xml 1073 1078 1067 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-ehp-117-203">1998b</xref>
###xml 1080 1099 1074 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp-117-203">Bonassi et al. 2000</xref>
###xml 1101 1119 1095 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-ehp-117-203">Hagmar et al. 1994</xref>
###xml 1121 1125 1115 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-ehp-117-203">1998</xref>
###xml 1127 1131 1121 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-ehp-117-203">2004</xref>
###xml 1133 1153 1127 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-ehp-117-203">Hansteen et al. 1978</xref>
###xml 1155 1159 1149 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-ehp-117-203">1984</xref>
###xml 1161 1180 1155 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-ehp-117-203">Knudsen et al. 1992</xref>
###xml 1182 1199 1176 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-ehp-117-203">Landi et al. 1999</xref>
###xml 1201 1220 1195 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31-ehp-117-203">Milillo et al. 1996</xref>
In all participating laboratories, the standard cytogenetic protocol was applied using heparinized whole blood and harvesting the cells after 48 hr of culture (Buckton and Evans 1973). CA preparations were stained with Giemsa. In Italy, the slides were banked at -20degreesC at the time of the original cytogenetic study (1991-1993) and stained in Giemsa immediately before the new CA analysis. In Italy, 150 and in Denmark, 100 metaphases per donor were scored for CA by a single scorer. In Norway, 100 or (in more recent studies) 200 cells per subject were scored by the same three microscopists. Savage's classification criteria for CA were used (Savage 1976). Total CA was defined as the number of cells with aberrations, excluding gaps, per 100 cells. To standardize for interlaboratory variation, all subjects were classified as low (1-33 percentile), medium (34-66 percentile), or high (67-100 percentile) according to tertiles of CA frequency distribution. More details on the laboratory protocols can be found in previously published reports (Barale et al. 1998a, 1998b; Bonassi et al. 2000; Hagmar et al. 1994, 1998, 2004; Hansteen et al. 1978, 1984; Knudsen et al. 1992; Landi et al. 1999; Milillo et al. 1996). The study protocols were approved by the ethics committees and legal authorities in each country.
###end p 24
###begin title 25
DNA extraction and genotype analysis
###end title 25
###begin p 26
###xml 85 105 85 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-ehp-117-203">Murgia et al. (2007)</xref>
###xml 193 216 193 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40-ehp-117-203">Skjelbred et al. (2006)</xref>
###xml 536 537 528 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 600 601 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
In Italy, genomic DNA was extracted from frozen whole blood or serum as described by Murgia et al. (2007). In Norway, DNA was extracted from fixed cell suspensions with the method described by Skjelbred et al. (2006). When cell suspensions were not available, DNA was extracted from unstained slides kept at room temperature for 3-26 years. The slides were hydrated, dried carefully before adding 100 muL buffer (50 mM Tris, 1 mM EDTA, 0.5% Triton 100), covered with plastic film, kept for 15 min at 56degreesC, scraped in 50-100 muL dH2O 2-4 times (total volume 200 muL), and centrifuged at 3,000 x g for 5 min; 50 muL buffer (as above) and 5 muL proteinase K (20 mg/mL) were added to the pellet. The samples were kept on a Thermomixer (Eppendorf, Hamburg, Germany) at 56degreesC, 1,000 rpm for 3 hr, before deactivating the enzyme on the Thermomixer at 96degreesC, 1,000 rpm for 10 min. The suspensions were stored at -20degreesC. The success rate depended upon the amount of cells, the age of the slides, and the genotype tested. In Denmark, DNA from mononuclear blood cells, originally analyzed for DNA repair by the unscheduled DNA synthesis technique and stored frozen in 0.4 M phosphate buffer in 1987, was used for the genotyping. This DNA had been isolated by using Millipore (Bedford, MA, USA) Microcon YM-30 centrifugal filter devices.
###end p 26
###begin p 27
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 104 124 104 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-ehp-117-203">Murgia et al. (2007)</xref>
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 179 184 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 287 322 287 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33-ehp-117-203">Nedelcheva Kristensen et al. (1998)</xref>
###xml 412 428 412 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27-ehp-117-203">Ko et al. (2000)</xref>
In Italy, genotype analysis was performed by a specific multiplex GSTT1/GSTM1 PCR assay as described by Murgia et al. (2007). In Norway, polymorphisms of the GSTM1 and GSTT1 (and GSTP1) genes were analyzed simultaneously by multiplex polymerase chain reaction using primers described by Nedelcheva Kristensen et al. (1998). A detailed report of the methods used for genotyping the Danish samples can be found in Ko et al. (2000).
###end p 27
###begin title 28
Statistical analysis
###end title 28
###begin p 29
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 323 324 323 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 323 324 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>i</sub></italic>
###xml 374 375 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 375 376 375 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 375 376 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>i</sub></italic>
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 383 384 383 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 383 384 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>i</sub></italic>
###xml 404 405 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 405 406 405 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 405 406 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>i</sub></italic>
###xml 232 238 <span type="species:ncbi:9606">person</span>
As the response variable in the study was binary (cancer yes/no), we used the standard logistic regression approach in which the response variable is the log odds (or logit). The purpose was to estimate the probability that the ith person will develop a cancer, conditionally on the information about his/her CA frequency Ei [1 = L (low), 2 = M (medium), 3 = H (high)], age Ai, sex Ei, and smoking habit Si, which are the design variables (M1):
###end p 29
###begin p 30
To perform the analysis, we used the Gibbs sampler, which is a Monte Carlo Markov Chain (MCMC) sampling algorithm. MCMC is a class of methods for sampling from probability distributions based on constructing Markov chains. The iterative procedure simulates a Markov chain, which has the desired posterior distribution as its stationary distribution.
###end p 30
###begin p 31
###xml 45 61 45 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-ehp-117-203">Lunn et al. 2000</xref>
###xml 315 334 315 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9-ehp-117-203">Bonassi et al. 2008</xref>
###xml 802 807 802 803 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#963;</bold>
###xml 838 843 834 835 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#963;</bold>
###xml 948 971 940 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3-ehp-117-203">Birkes and Dodge (1993)</xref>
###xml 976 996 968 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15-ehp-117-203">Gelman et al. (1995)</xref>
###xml 1057 1061 1049 1050 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</bold>
###xml 1061 1062 1050 1051 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1067 1071 1056 1057 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</bold>
###xml 1071 1072 1057 1058 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1493 1502 1479 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-ehp-117-203">IARC 1986</xref>
###xml 1615 1616 1601 1602 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</bold>
###xml 1476 1483 <span type="species:ncbi:4097">tobacco</span>
We used the statistical software WinBUGS () (Lunn et al. 2000) to set up a Bayesian model specifying an informative normal prior distribution for the regression coefficients where existing knowledge was available. More precisely, from the pooled cohort analysis of 22,358 subjects examined for CAs in 11 countries (Bonassi et al. 2008), we knew that the overall odds ratio (OR) for the medium tertile compared with the low was 1.3 with a 95% confidence interval (CI) of 1.07-1.60, and that the OR for the highest tertile was 1.4 (1.16-1.72). The assumption that the log OR is normally distributed leads to a normal distribution with mean value given by ln(1.3) = 0.26 and ln(1.4) = 0.33, respectively. The standard deviation of the normal distributions was found by solving the equations 1n(1.3) + 1.96sigma = 1n(1.60) and 1n(1.4) + 1.96 sigma = 1n(1.72), which gave a standard deviation on the log odds scale of 0.1 in both cases. As suggested by Birkes and Dodge (1993) and Gelman et al. (1995), a simple way to provide a prior variance on the parameters beta1 and beta2 in the current study was to inflate the historical variance. To take into account the heterogeneity and other differences between current and historical data, we considered the prior variance as a Gamma random variable which, on average, fluctuated around the inflating factor (60 in our case). Further prior information was obtained from International Agency for Research on Cancer (IARC) monograph on tobacco smoking (IARC 1986): (weighted) mean value of OR (current vs. never smokers) was considered 10 for lung cancer, 1.4 for oral cavity-digestive tract cancers, and 2.1 for genitourinary organ cancers. With regard to the Bayesian interval estimation of OR, we adopted the 95% credibility interval (CrI) with the highest posterior density, that is, an interval of the OR posterior distribution such that the area under the curve is 0.95 and the density at any point inside the interval is greater than the density at any point outside. The traditional CI based on frequentist inference refers to repeated sampling, random intervals, and true parameter values (OR) and does not provide any estimates concerning the study that was actually conducted. On the contrary, CrI is a probability statement within the data set studied concerning the random variable OR and specifying the range within which the OR lies with 0.95 probability.
###end p 31
###begin p 32
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 378 381 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BIC</italic>
###xml 388 389 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 389 390 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 389 390 389 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>m</sub></italic>
###xml 393 394 393 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 396 397 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 405 406 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 427 428 427 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 494 495 494 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 495 496 495 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 495 496 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>m</sub></italic>
To estimate if the GSTM1 null and GSTT1 null genotypes were a risk factor for all cancers, we used a similar multivariate analysis, adding to the model M1 described in Equation 1 the variables GSTM1, GSTT1 (we called this model M2) and their interactions within CA (we called this model M3). The analysis performed to choose between competing models was based on the BIC index, BIC = -21nLm + m1nn, where n is the sample size, m is the difference of the number of parameters in the models, and Lm is the likelihood ratio for the models. This criterion penalized models that improved the fit, increasing the number of parameters. The model with the lower value of BIC was the one to be preferred.
###end p 32
###begin title 33
Results
###end title 33
###begin p 34
###xml 134 141 134 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1-ehp-117-203">Table 1</xref>
###xml 560 567 560 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2-ehp-117-203">Table 2</xref>
###xml 411 416 <span type="species:ncbi:9606">women</span>
The distribution of cases and controls in the whole database by country and by other variables considered in the analysis is given in Table 1. The proportion of males and of current smokers was higher in the databases from Norway and Denmark. Smoking habit was not different between the cases and controls. The Italian subjects selected from the general population had a higher mean age, a higher proportion of women, and fewer current smokers than the Nordic groups. The distribution by tumor site of the 107 cancer cases included in the study is reported in Table 2.
###end p 34
###begin p 35
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 145 152 145 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-ehp-117-203">Table 3</xref>
###xml 299 304 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 431 438 431 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-ehp-117-203">Table 3</xref>
The distribution of GST polymorphisms did not differ significantly in the three countries, and therefore all data were combined before analysis (Table 3). No significant differences were evident in the genotype distribution of cases and controls, with null genotype prevalence of 52.4 and 50.5% for GSTM1 and 29.9 and 29.8% for GSTT1, respectively. Accordingly, the mean frequency of CA did not appear to be modulated by genotype (Table 3).
###end p 35
###begin p 36
###xml 163 164 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 171 172 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The univariate analysis comparing the overall mean CA frequency (SE) in cases and controls [1.98 (0.14) vs. 1.38 (0.14)] revealed a highly significant difference (t-test, p = 0.006). At the national level, cancer cases had a significantly higher mean CA frequency in the Danish and Italian databases (data not shown).
###end p 36
###begin p 37
###xml 98 105 98 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4-ehp-117-203">Table 4</xref>
The results of the multivariate Bayesian model linking CA tertile and cancer risk are reported in Table 4. No effect of sex or age were observed; smoking habit increased the overall risk of cancer but did not confound or modify the effect of CA level on cancer risk. The overall analysis showed a borderline risk increase for subjects in the medium tertile of CA distribution (OR = 1.5; 95% CrI, 0.88-2.50) and an increase for those in the high tertile (OR = 2.8; 95% CrI, 1.6-4.6) when compared with the lowest tertile. Increased cancer risks for the medium and high tertiles were found in all national data sets, although only in the highest tertile of the Italian subset did the CrI not include 1 (OR = 9.4; 95% CrI, 2.6-28.0).
###end p 37
###begin p 38
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 448 453 448 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 496 502 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1.</italic>
The possible role of GSTM1 and GSTT1 genetic polymorphisms as effect modifiers of the association between CA frequency and cancer risk was tested in the Bayesian models (model M3 vs. model M2). The analysis, based on the BIC index, favored the model without interaction terms (M2), ruling against the hypothesis that the cancer risk predictivity of CA frequency could be modified by these polymorphisms, i.e., BIC(M3) = 481.9 > BIC(M2) = 473.1 for GSTM1 and BIC(M3) = 365.5 > BIC(M2) = 357.7 for GSTT1.
###end p 38
###begin p 39
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 373 379 373 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1.</italic>
A similar multivariate model was used to estimate if the GSTM1 null and GSTT1 null genotypes were a risk factor for all cancers (model M2 vs. model M1). Again, the BIC index did not show any increase in the null genotypes, as anticipated by the results of the univariate analysis, i.e., BIC(M2) = 473.1 > BIC(M1) = 467.3 for GSTM1 and BIC(M2) = 357.7 > BIC(M1) = 352.6 for GSTT1.
###end p 39
###begin p 40
###xml 168 175 168 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5-ehp-117-203">Table 5</xref>
Finally, we fitted multivariate Bayesian models to major cancer sites to test the hypothesis that CA frequency could more specifically predict the risk by cancer type (Table 5). Credible associations (see statistical methods for a definition of credibility intervals) were found with the high tertile of the CA distribution for cancers of the genitourinary tract (OR = 4.0; 95% CrI, 1.4-10.0); respiratory tract (OR = 6.2; 95% CrI, 1.5-20.0), and digestive tract (OR = 2.8; 95% CrI, 1.2-5.8).
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 257 262 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
The results of this case-control study provide new information for the validation of CA as a biomarker of cancer risk. Although the study groups were rather small, our findings suggest that the association between CA and cancer is not modified by GSTM1 and GSTT1 polymorphisms, that the association is higher when the evaluation is based on uniform cytogenetic data rather than pooled historical data, and that the use of Bayesian modeling is a credible approach for risk estimation in case of sparse data, a common condition in biomarker validation studies.
###end p 42
###begin p 43
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 370 375 370 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 511 530 511 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6-ehp-117-203">Bolufer et al. 2006</xref>
###xml 532 551 532 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-ehp-117-203">Bolt and Thier 2006</xref>
###xml 553 573 553 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-ehp-117-203">Carlsten et al. 2008</xref>
###xml 575 593 575 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-ehp-117-203">Hiyama et al. 2008</xref>
###xml 595 604 595 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36-ehp-117-203">Parl 2005</xref>
###xml 606 621 606 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39-ehp-117-203">Shi et al. 2008</xref>
###xml 623 641 623 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43-ehp-117-203">Vineis et al. 2007</xref>
###xml 643 660 643 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45-ehp-117-203">White et al. 2008</xref>
###xml 698 703 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 708 713 708 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 894 905 894 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-ehp-117-203">Norppa 2004</xref>
###xml 907 926 907 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42-ehp-117-203">Tuimala et al. 2004</xref>
###xml 928 947 928 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44-ehp-117-203">Vodicka et al. 2004</xref>
###xml 1129 1132 1129 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 1135 1149 1135 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23-ehp-117-203">Hu et al. 2006</xref>
###xml 1151 1172 1151 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-ehp-117-203">Kligerman and Hu 2007</xref>
###xml 1282 1285 1282 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
Our study offered a rare opportunity to assess the impact of genetic polymorphisms on the relationship between chromosomal damage and cancer risk with a longitudinal design. We were able to evaluate only two genotypes, that is GSTM1 and GSTT1, because of the limited amount of DNA available for each subject. Previous data have suggested that the null genotypes of both GSTM1 and GSTT1 are associated with a slightly increased risk of some forms of cancer, although this does not appear to concern all cancers (Bolufer et al. 2006; Bolt and Thier 2006; Carlsten et al. 2008; Hiyama et al. 2008; Parl 2005; Shi et al. 2008; Vineis et al. 2007; White et al. 2008). There is also evidence in favor of GSTM1 and GSTT1 genotypes affecting the level of CA in lymphocytes especially in smokers, although most studies have suggested no clear effects of either polymorphism on the baseline level of CA (Norppa 2004; Tuimala et al. 2004; Vodicka et al. 2004). Furthermore, the possible presence of heterogeneity in the genetic background of national populations, as well as the activation of carcinogens occasionally caused by polymorphic GSTs (Hu et al. 2006; Kligerman and Hu 2007), may have weakened the associations studied. Thus, our negative findings on the modifying effect of the two GST polymorphisms on the association between CA and cancer risk seem to agree with the existing information about their negligible influence on total cancer risk and baseline CA level. Our conclusions are, however, limited by the small size of the study groups, which did not allow assessing possible interactions between genotype and smoking. Moreover, the genotype data were obtained using different sources of DNA, and thereby different methods, for DNA isolation and genotyping in the participating laboratories.
###end p 43
###begin p 44
###xml 110 129 110 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp-117-203">Bonassi et al. 2000</xref>
In general, the present findings confirmed, largely with new data, the results published by the ESCH in 2000 (Bonassi et al. 2000)-that cancer prediction based on CA frequency is independent of smoking and exposure to carcinogens.
###end p 44
###begin p 45
###xml 106 125 106 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42-ehp-117-203">Tuimala et al. 2004</xref>
###xml 127 146 127 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44-ehp-117-203">Vodicka et al. 2004</xref>
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XRCC1</italic>
###xml 349 354 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XRCC3</italic>
###xml 449 454 449 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ERCC2</italic>
###xml 597 602 597 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 708 729 708 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40-ehp-117-203">Skjelbred et al. 2006</xref>
###xml 999 1010 999 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-ehp-117-203">Norppa 2004</xref>
###xml 1012 1033 1012 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40-ehp-117-203">Skjelbred et al. 2006</xref>
###xml 1035 1054 1035 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42-ehp-117-203">Tuimala et al. 2004</xref>
###xml 1056 1075 1056 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44-ehp-117-203">Vodicka et al. 2004</xref>
###xml 305 320 <span type="species:ncbi:10029">Chinese hamster</span>
###xml 403 418 <span type="species:ncbi:10029">Chinese hamster</span>
The polymorphisms of other genes, such as those involved in DNA repair, might have been relevant as well (Tuimala et al. 2004; Vodicka et al. 2004). However, polymorphisms in the DNA repair genes OGG1 (8-oxoguanine DNA glycosylase; U96710, GeneBank), XRCC1 (X-ray repair complementing defective repair in Chinese hamster cells 1; M36089, GeneBank), XRCC3 (X-ray repair complementing defective repair in Chinese hamster cells 3; AF035586, GeneBank), ERCC2 (exicision repair cross-complementing rodent repair deficiency, complementation group 2; HGNC:3434, GeneBank), and the folate metabolism gene MTHFR (5,10-methylenetetrahydrofolate reductase; BC053509, GeneBank) were evaluated in the Norwegian data set (Skjelbred et al. 2006) and explained only 4-10% of the variance in CA, suggesting that these polymorphisms would not have strong effects on the association between CA frequency and cancer risk. Although many genetic polymorphisms have been observed to affect the level of chromosome damage (Norppa 2004; Skjelbred et al. 2006; Tuimala et al. 2004; Vodicka et al. 2004), single or a few genes may be expected to have only a small effect on CA frequency.
###end p 45
###begin p 46
###xml 476 495 476 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp-117-203">Barale et al. 1998a</xref>
###xml 497 502 497 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-ehp-117-203">1998b</xref>
###xml 504 521 504 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-ehp-117-203">Landi et al. 1999</xref>
###xml 523 542 523 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31-ehp-117-203">Milillo et al. 1996</xref>
###xml 891 907 891 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29-ehp-117-203">Liou et al. 1999</xref>
###xml 1133 1153 1133 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-ehp-117-203">Boffetta et al. 2007</xref>
###xml 1155 1174 1155 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7-ehp-117-203">Bonassi et al. 1995</xref>
###xml 1176 1180 1176 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp-117-203">2000</xref>
###xml 1182 1186 1182 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11-ehp-117-203">2004</xref>
###xml 1188 1207 1188 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-ehp-117-203">Br&#248;gger et al. 1990</xref>
###xml 1209 1227 1209 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-ehp-117-203">Hagmar et al. 1994</xref>
###xml 1229 1233 1229 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-ehp-117-203">1998</xref>
###xml 1235 1239 1235 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-ehp-117-203">2004</xref>
###xml 1241 1257 1241 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29-ehp-117-203">Liou et al. 1999</xref>
###xml 1259 1278 1259 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37-ehp-117-203">Rossner et al. 2005</xref>
###xml 2295 2314 2295 2314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10-ehp-117-203">Bonassi et al. 2005</xref>
###xml 2316 2334 2316 2334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35-ehp-117-203">Norppa et al. 2006</xref>
###xml 1919 1925 <span type="species:ncbi:9606">person</span>
Most studies of CA and cancer risk have been multicentric, and the cytogenetic data generated during many years in a number of laboratories are subject to methodologic variability due to multiple scorers and differences in cell culture, slide preparation, staining, and analysis. A unique feature of the current Italian data was that the cytogenetic slides of the cancer cases and selected controls, originating from surveillance studies performed in Pisa in the early 1990s (Barale et al. 1998a, 1998b; Landi et al. 1999; Milillo et al. 1996), were retrieved from the freezer, stained, and consecutively scored for CA by a single microscopist specifically for the present study. Most probably, such procedure reduced technical variability, and this is the most likely explanation for the very high risk estimates in Pisa, previously reported only by another case-control study from Taiwan (Liou et al. 1999). This observation raises an interesting point concerning the use of CA as a biomarker of cancer risk. The cancer risk associated with a high frequency of CA, although consistently detected in all studies thus far published (Boffetta et al. 2007; Bonassi et al. 1995, 2000, 2004; Brogger et al. 1990; Hagmar et al. 1994, 1998, 2004; Liou et al. 1999; Rossner et al. 2005), has generally been low and variable. Therefore, it has been considered that CA can hardly be applied for individual risk assessment. If the findings of this study are confirmed, and a stronger association between CA frequency and cancer risk can be obtained by reducing technical variability, the perspective for the use of this biomarker in cancer prevention may have to be rethought. Uniform CA analysis is a routine practice in cytogenetic surveillance studies, which are mostly interpreted at the group level, with the exception of radiation biodosimetry. For group-level evaluation, the present practice of scoring 100-200 cells per person is adequate, but it is likely not sufficient for reliable individual CA assessment. However, if the level of CA had, in reality, a stronger association with cancer risk than has thus far been assumed, reasonable individual cancer risk estimation might become feasible with extended CA analysis. At any rate, our findings lend further support to earlier considerations (Bonassi et al. 2005; Norppa et al. 2006) that the CA assay could be used more widely in estimating cancer risk at the group level.
###end p 46
###begin p 47
###xml 308 327 308 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37-ehp-117-203">Rossner et al. 2005</xref>
###xml 391 411 391 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-ehp-117-203">Boffetta et al. 2007</xref>
###xml 763 769 763 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad hoc</italic>
###xml 919 940 919 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16-ehp-117-203">Greenland et al. 2000</xref>
Another innovative feature of the present study was the potential provided by the Bayesian approach for improving the reliability of the estimates based on data from small groups, as often happens with biomarker validation studies. Most recent results from large CA cohort studies, such as the Czech cohort (Rossner et al. 2005) and the new cohort of Central and Eastern European countries (Boffetta et al. 2007), described stronger associations with specific cancers. In smaller cohorts and in case-control studies, risk estimates based on classic frequentist modeling are likely to produce unreliable estimates in small strata, and any likelihood-based analysis for small data, or even worse, missing data, usually involves computationally intensive methods or ad hoc adjustments. Even without epidemiologic biases, the presence of small counts indicates that large statistical biases may affect the point estimates (Greenland et al. 2000).
###end p 47
###begin p 48
In contrast, the Bayesian analysis allows one to efficiently manage extra information, sparse data, and missing covariates. In the present study, MCMC sampling enabled us to make inferences for any sample size without resorting to asymptotic calculations. In many cases, a frequentist inference can be obtained as a special case of the Bayesian inference, and when vague prior information is used, point and interval estimates are similar to the frequentist counterpart. However, the fundamental difference is the interpretation of intervals of variability associated with risk estimates. This is the best possible description of risk variability within the study context. If the study is correctly designed and the prior information is correctly selected, this risk range provides the most credible assessment of risk variability.
###end p 48
###begin p 49
###xml 185 205 185 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-ehp-117-203">Boffetta et al. 2007</xref>
###xml 207 226 207 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37-ehp-117-203">Rossner et al. 2005</xref>
###xml 251 270 251 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7-ehp-117-203">Bonassi et al. 1995</xref>
Interestingly, the present results showed the strongest associations of CA with the same cancer types reported by the cohort studies mentioned above, that is, cancers of the digestive (Boffetta et al. 2007; Rossner et al. 2005) and respiratory tract (Bonassi et al. 1995), although the numbers of specific cancer cases in the present evaluation were small.
###end p 49
###begin p 50
###xml 528 533 528 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 538 543 538 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
In conclusion, this nested case-control study provided relevant new information for interpreting the role of chromosomal damage in carcinogenesis. In particular, it suggested that reducing technical variability in the cytogenetic analysis may increase the strength of the association between CA and cancer risk, with possible implications for the results provided by cohort studies published so far, which were affected by large discrepancies in laboratory protocols and scoring. The negative result concerning the influence of GSTM1 and GSTT1 polymorphisms, despite the intrinsic limitation due to small numbers, is in agreement with the idea that individual polymorphisms are not expected to have a dramatic influence on baseline CA level or overall cancer risk. Our findings support the hypothesis that CA frequency, although indirectly measured in surrogate tissues, can predict the risk of cancer by itself as a phenotypic manifestation of multiple carcinogenic processes or as an intermediate step of a causal process. This conclusion is of great value for the use of CA as biomarker in cancer prevention policies.
###end p 50
###begin p 51
The Cancer Registry of Norway is not responsible for the analysis or interpretation of the data presented.
###end p 51
###begin p 52
This work was supported by grants from the European Union 5th FP (QLRT-2000-00628) and its extension (QLK4-CT-2002-02831), the Associazione Italiana per la Ricerca sul Cancro (AIRC), the Italian Ministry of Health, the Italian Space Agency (ASI), the Telemark Hospital (Research and Development), the Fondazione Buzzi-Unicem per la Ricerca sul Mesotelioma, Casale (Italy), the Danish National Programme of Environmental Health Research on Cancer (0-302-02-4/2), and the Finnish Work Environment Fund.
###end p 52
###begin title 53
References
###end title 53
###begin article-title 54
###xml 56 61 <span type="species:ncbi:9606">human</span>
Sister chromatid exchange and micronucleus frequency in human lymphocytes of 1,650 subjects in an Italian population. II. Contribution of sex, age, and lifestyle
###end article-title 54
###begin article-title 55
###xml 56 61 <span type="species:ncbi:9606">human</span>
Sister chromatid exchange and micronucleus frequency in human lymphocytes of 1,650 subjects in an Italian population. I. Contribution of methodological factors
###end article-title 55
###begin article-title 56
Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe
###end article-title 56
###begin article-title 57
###xml 59 60 59 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology
###end article-title 57
###begin article-title 58
Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression
###end article-title 58
###begin article-title 59
###xml 93 99 <span type="species:ncbi:9606">humans</span>
Are chromosome aberrations in circulating lymphocytes predictive of a future cancer onset in humans? Preliminary results of an Italian cohort study
###end article-title 59
###begin article-title 60
###xml 47 52 <span type="species:ncbi:9606">human</span>
Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens
###end article-title 60
###begin article-title 61
Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22,358 subjects in 11 countries
###end article-title 61
###begin article-title 62
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human population studies with cytogenetic biomarkers: review of the literature and future prospects
###end article-title 62
###begin article-title 63
###xml 46 52 <span type="species:ncbi:9606">humans</span>
Chromosomal aberrations and risk of cancer in humans: an epidemiological perspective
###end article-title 63
###begin article-title 64
An inter-Nordic prospective study on cytogenetic endpoints and cancer risk. Nordic Study Group on the Health Risk of Chromosome Damage
###end article-title 64
###begin article-title 65
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis
###end article-title 65
###begin article-title 66
Problems due to small sample and sparse data in conditional logistic regression
###end article-title 66
###begin article-title 67
###xml 47 52 <span type="species:ncbi:9606">human</span>
Chromosomal aberrations in lymphocytes predict human cancer - a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH)
###end article-title 67
###begin article-title 68
###xml 15 21 <span type="species:ncbi:9606">humans</span>
Cancer risk in humans predicted by increased levels of chromosome aberrations in lymphocytes: Nordic Study Group on the Health Risk of Chromosome Damage
###end article-title 68
###begin article-title 69
###xml 57 62 <span type="species:ncbi:9606">human</span>
Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts
###end article-title 69
###begin article-title 70
###xml 29 32 <span type="species:ncbi:9606">man</span>
Effects of vinyl chloride in man: a cytogenetic follow-up study
###end article-title 70
###begin article-title 71
###xml 4 9 <span type="species:ncbi:9606">human</span>
Low human exposure to styrene in relation to chromosome breaks, gaps and sister chromatid exchanges
###end article-title 71
###begin article-title 72
Genetic polymorphisms and head and neck cancer risk
###end article-title 72
###begin article-title 73
###xml 114 115 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 95 101 <span type="species:ncbi:10090">murine</span>
Induction of DNA-protein crosslinks by dichloromethane in a V79 cell line transfected with the murine glutathione-S-transferase theta 1 gene
###end article-title 73
###begin article-title 74
###xml 0 7 <span type="species:ncbi:4097">Tobacco</span>
Tobacco Smoking
###end article-title 74
###begin article-title 75
Some insights into the mode of action of butadiene by examining the genotoxicity of its metabolites
###end article-title 75
###begin article-title 76
Biomonitoring of genotoxic exposure among stainless steel welders
###end article-title 76
###begin article-title 77
###xml 18 30 18 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1, GSTT1</italic>
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
Rapid analysis of GSTM1, GSTT1 and GSTP1 polymorphisms using real-time polymerase chain reaction
###end article-title 77
###begin article-title 78
###xml 77 83 <span type="species:ncbi:9606">humans</span>
Spontaneous sister chromatid exchange and chromosome aberration frequency in humans: the familial effect
###end article-title 78
###begin article-title 79
Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a black-foot endemic area
###end article-title 79
###begin article-title 80
WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility
###end article-title 80
###begin article-title 81
###xml 26 32 <span type="species:ncbi:9606">humans</span>
Chromosome aberrations in humans in relation to site of residence
###end article-title 81
###begin article-title 82
Micronuclei, genetic polymorphisms and cardiovascular disease mortality in a nested case-control study in Italy
###end article-title 82
###begin article-title 83
###xml 188 196 <span type="species:ncbi:9606">patients</span>
Single tube multiplex polymerase chain reaction geneotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients
###end article-title 83
###begin article-title 84
Cytogenetic biomarkers and genetic polymorphisms
###end article-title 84
###begin article-title 85
Chromosomal aberrations and SCEs as biomarkers of cancer risk
###end article-title 85
###begin article-title 86
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
Glutathione S-transferase genotypes and cancer risk
###end article-title 86
###begin article-title 87
Chromosomal aberration in lymphocytes of healthy subjects and risk of cancer
###end article-title 87
###begin article-title 88
Classification and relationships of induced chromosomal structural changes
###end article-title 88
###begin article-title 89
CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis
###end article-title 89
###begin article-title 90
Influence of DNA repair gene polymorphisms of hOGG1, XRCC1, XRCC3, ERCC2 and the folate metabolism gene MTHFR on chromosomal aberration frequencies
###end article-title 90
###begin article-title 91
Increased risk of cancer in radon-exposed miners with elevated frequency of chromosomal aberrations
###end article-title 91
###begin article-title 92
Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: effects on levels of sister chromatid exchanges and chromosomal aberrations
###end article-title 92
###begin article-title 93
Evidence of gene gene interactions in lung carcinogenesis in a large pooled analysis
###end article-title 93
###begin article-title 94
Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA
###end article-title 94
###begin article-title 95
###xml 32 33 32 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
Genetic variants of glutathione S-transferase as possible risk factors-for hepatocellular carcinoma: a HuGE systematic review and meta-analysis
###end article-title 95
###begin p 96
Number of cancer cases and controls classified according to sex, age, and smoking status.
###end p 96
###begin p 97
At the time of CA sampling. For one case and eight controls from Norway, no data were available on smoking status.
###end p 97
###begin p 98
Distribution of cancer cases included in the nested case-control study by site and country.
###end p 98
###begin p 99
###xml 56 64 56 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46-ehp-117-203">WHO 1975</xref>
International Classification of Diseases, 9th Revision (WHO 1975).
###end p 99
###begin p 100
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 86 87 86 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="tfn3-ehp-117-203">a</xref>
Distribution of GSTM1 and GSTT1 genotypes in cases and controls and mean CA frequency.a
###end p 100
###begin p 101
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
Because of the limited amount of DNA retrieved from stored specimen, only 105/107 cases were genotyped for GSTM1 and 77/107 for GSTT1.
###end p 101
###begin p 102
###xml 86 87 86 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="tfn4-ehp-117-203">a</xref>
Multivariate Bayesian estimates of cancer risk by tertiles of CA frequency by country.a
###end p 102
###begin p 103
Estimates based on 20,000 (MCMC) updates.
###end p 103
###begin p 104
Multivariate Bayesian risk estimates of cancer risk by tertiles of CA frequency and by cancer site.
###end p 104

